Keith R Abrams

9PUBLICATIONS
52CO-AUTHORS
Molecular targetsPharmaceutical delivery technologiesImmunogenetics (incl. genetic immunology)Econometric and statistical methodsDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 19, 2025
Clinical Benefit From Molecularly Guided Cancer Care: A Matching-Adjusted Indirect Comparison of Larotrectinib Versus Standard of Care.

Carsten Bokemeyer, Keith R Abrams, Jesus Garcia-Foncillas

|Oct 11, 2024
Advancing the role of real-world evidence in comparative effectiveness research.

Monica Daigl, Seye Abogunrin, Felipe Castro

|Jun 29, 2023
Prognostic Value of Neurotrophic Tyrosine Receptor Kinase Gene Fusions in Solid Tumors for Overall Survival: A Systematic Review and Meta-Analysis.

Ulrik Lassen, Carsten Bokemeyer, Jesus Garcia-Foncillas

|Jun 12, 2023
Cost-Effectiveness Analysis of Siltuximab for Australian Public Investment in the Rare Condition Idiopathic Multicentric Castleman Disease.

Francis Shupo, Keith R Abrams, Zanfina Ademi

|Aug 06, 2022
Use of copula to model within-study association in bivariate meta-analysis of binomial data at the aggregate level: A Bayesian approach and application to surrogate endpoint evaluation.

Tasos Papanikos, John R Thompson, Keith R Abrams

|May 26, 2022
Risk factors associated with SARS-CoV-2 infection in a multiethnic cohort of United Kingdom healthcare workers (UK-REACH): A cross-sectional analysis.

Christopher A Martin, Daniel Pan, Carl Melbourne

Pageof 2

Frequent Collaborators

2 joint publications

Ulrik Lassen

2 joint publications

Carsten Bokemeyer

2 joint publications

Jesus Garcia-Foncillas

2 joint publications

Antoine Italiano